CABG Surgery Vs PCI In Diabetics With Coronary Artery Disease

Two weeks ago, I reported on a prospectivethose of non-diabetic patients to narrow again
randomized clinical trial that compared coronaryfollowing PCI using balloon angioplasty, with or
artery bypass surgery (CABG) with coronarywithout the insertion of bare metal stents.
artery angioplasty and stent placementHowever, recent advances in the development of
(percutaneous coronary intervention, or PCI). Idrug-eluting stents and newer anti-clotting drugs
noted that, based upon the early results of thishave shown considerable promise in diabetic
clinical study, the jury may still be out regardingpatients undergoing PCI with stent placement
which of these two treatment approaches to(among the 10 clinical studies included in this
coronary artery narrowing (stenosis) offers theanalysis, all patients receiving PCI underwent
best risk-to-benefit equation for most patients.balloon angioplasty with or without bare metal
Now, a new report, just published in The Lancet,stent placement, and no drug-eluting stents were
has analyzed the results of 10 differentutilized).
prospective randomized clinical research trialsFortunately, there are several ongoing prospective
comparing CABG with PCI in the treatment ofrandomized clinical research trials that will,
coronary artery disease affecting multiplehopefully, shed more light on the coronary artery
coronary arteries.restenosis rate in diabetic patients using the
Altogether, the 10 clinical trials evaluated in thisnewer drug-eluting stents and glycoprotein IIb/IIIa
report included 7,812 patient volunteers. After aninhibiting drugs. Unfortunately, we will have to
average of 6 years of clinical follow-up, 575 ofawait the publication of the findings of these
the 3,889 (15 percent) patients who underwentongoing clinical trials before PCI can truly be
CABG died, while 628 of the 3,923 (16 percent)declared equal to CABG in diabetic patients.
patients who underwent PCI died. Therefore,Therefore, at the present time, patients with
overall, there was no difference in survivaldiabetes, and especially diabetic patients with
between the two treatment groups within 6more advanced multi-vessel coronary artery
years of coronary artery intervention. However,disease (as well as diabetic patients with abnormal
when the researchers analyzed certain groups offunction of the primary pumping chamber of the
patients undergoing coronary artery interventions,heart, the left ventricle) are more likely to be
they discovered that diabetic patients appeared toadvised to undergo CABG instead of PCI; although
do much better following CABG, rather than PCI.an increasing number of favorable-risk diabetic
Among the patients with diabetes, survival at 6patients with complicated coronary artery disease
years after treatment was 30 percent greaterare now being offered PCI with the newer
among those diabetic patients who underwentdrug-eluting stents and anti-clotting drugs.
CABG when compared to the diabetic patientsAs I concluded 2 weeks ago, the ongoing
who underwent PCI. Similarly, patients over theimprovements in minimally-invasive PCI have
age of 65 also appeared to do better with CABG.definitely narrowed the gap in clinical outcomes
Among patients over the age of 65, survival at 6between PCI and CABG over the past 10 to 15
years was 18 percent better in the CABG groupyears, and it is no longer clear that CABG (which
when compared to the PCI group. For all otheris much more invasive than PCI, and more likely
patients, however, there was no statisticallyto cause stroke than PCI) offers any significant
significant difference in survival at 6 yearssurvival benefit over PCI, although CABG does
between those patients who underwent PCI andappear to still provide a longer duration of
those who underwent the far more invasiveimprovement in blood flow to the heart than PCI
CABG surgery.(however, PCI can often be repeated, when
Approximately 1.5 million coronary arterynecessary), and CABG may still be more
interventions (CABG and PCI) are performed inappropriate for patients with more advanced
the United States each year, and an estimated 25cases of multi-vessel coronary artery disease.
percent of these patients have diabetes. So, aStay tuned, as I will continue to track the results
significant number of patients undergoing CABGof this very important area of clinical research,
and PCI also have diabetes. The results of thisand I will keep readers updated as the ongoing
analysis are in keeping with the findings of"CABG vs. PCI" clinical research trials begin to
previous studies showing that the coronaryreport their results.
arteries of diabetic patients are more likely than